Cargando…
Investigation of Neurodevelopmental Deficits of 22 q11.2 Deletion Syndrome with a Patient-iPSC-Derived Blood–Brain Barrier Model
The blood–brain barrier (BBB) is important in the normal functioning of the central nervous system. An altered BBB has been described in various neuropsychiatric disorders, including schizophrenia. However, the cellular and molecular mechanisms of such alterations remain unclear. Here, we investigat...
Autores principales: | Li, Yunfei, Xia, Yifan, Zhu, Huixiang, Luu, Eric, Huang, Guangyao, Sun, Yan, Sun, Kevin, Markx, Sander, Leong, Kam W., Xu, Bin, Fu, Bingmei M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8534009/ https://www.ncbi.nlm.nih.gov/pubmed/34685556 http://dx.doi.org/10.3390/cells10102576 |
Ejemplares similares
-
Inhibition of Abl Kinase by Imatinib Can Rescue the Compromised Barrier Function of 22q11.2DS Patient-iPSC-Derived Blood–Brain Barriers
por: Li, Yunfei, et al.
Publicado: (2023) -
Mitochondrial deficits in human iPSC-derived neurons from patients with 22q11.2 deletion syndrome and schizophrenia
por: Li, Jianping, et al.
Publicado: (2019) -
Integrative transcriptome network analysis of iPSC-derived neurons from schizophrenia and schizoaffective disorder patients with 22q11.2 deletion
por: Lin, Mingyan, et al.
Publicado: (2016) -
Visual processing deficits in 22q11.2 Deletion Syndrome
por: Biria, Marjan, et al.
Publicado: (2017) -
Neurodevelopmental Trajectories and Psychiatric Morbidity: Lessons Learned From the 22q11.2 Deletion Syndrome
por: Fiksinski, Ania M., et al.
Publicado: (2021)